Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: A cost-effectiveness analysis

Beth A. Plunkett; William A. Grobman

doi:10.1016/j.ajog.2004.05.062

Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: A cost-effectiveness analysis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2004.05.062 ◽

2004 ◽

Vol 191 (3) ◽

pp. 998-1003 ◽

Cited By ~ 8

Author(s):

Beth A. Plunkett ◽

William A. Grobman

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Cesarean Delivery ◽

Perinatal Transmission ◽

Cost Effectiveness Analysis ◽

Elective Cesarean Delivery ◽

Effectiveness Analysis ◽

Elective Cesarean

Download Full-text

Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: a cost-effectiveness analysis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2003.10.116 ◽

2003 ◽

Vol 189 (6) ◽

pp. S97 ◽

Cited By ~ 1

Author(s):

Beth Plunkett ◽

William Grobman

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Cesarean Delivery ◽

Perinatal Transmission ◽

Cost Effectiveness Analysis ◽

Elective Cesarean Delivery ◽

Effectiveness Analysis ◽

Elective Cesarean

Download Full-text

Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost-effectiveness analysis

Journal of Viral Hepatitis ◽

10.1111/jvh.13023 ◽

2018 ◽

Vol 26 (2) ◽

pp. 236-245 ◽

Cited By ~ 4

Author(s):

François Girardin ◽

Natalie Hearmon ◽

Francesco Negro ◽

Lucy Eddowes ◽

Philip Bruggmann ◽

...

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

People Who Inject Drugs ◽

Cost Effectiveness Analysis ◽

Dried Blood Spot ◽

Effectiveness Analysis ◽

Blood Spot ◽

Virus Screening ◽

Rapid Antibody

Download Full-text

Cost‐effectiveness analysis of hepatitis C virus (HCV) point‐of‐care assay for HCV screening

Liver International ◽

10.1111/liv.15123 ◽

2021 ◽

Author(s):

Vanessa Koo ◽

Feng Tian ◽

William W. L. Wong

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Point Of Care ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Hcv Screening ◽

Point Of Care Assay

Download Full-text

Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis

PharmacoEconomics ◽

10.1007/s40273-019-00864-8 ◽

2019 ◽

Vol 38 (2) ◽

pp. 233-242 ◽

Cited By ~ 7

Author(s):

T. Joseph Mattingly ◽

Julia F. Slejko ◽

Eberechukwu Onukwugha ◽

Eleanor M. Perfetto ◽

Shyamasundaran Kottilil ◽

...

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Cost Effectiveness Analysis ◽

Patient Centered ◽

Effectiveness Analysis

Download Full-text

PIN9 A COST-EFFECTIVENESS ANALYSIS OF A YEARLY FIBROSCAN® LIVER FIBROSIS ASSESSMENT COMPARED WITH A PERIODIC LIVER BIOPSY IN HEPATITIS C VIRUS (HCV) INFECTED INDIVIDUALS IN A FRENCH SETTING

Value in Health ◽

10.1016/s1098-3015(10)65516-7 ◽

2007 ◽

Vol 10 (6) ◽

pp. A438

Author(s):

K Levesque ◽

V De Lédinghen ◽

M Bourlière ◽

H Miadi-Fargier ◽

S Billon ◽

...

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Liver Fibrosis ◽

Liver Biopsy ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12871 ◽

2014 ◽

Vol 40 (6) ◽

pp. 657-675 ◽

Cited By ~ 50

Author(s):

S. Saab ◽

S. C. Gordon ◽

H. Park ◽

M. Sulkowski ◽

A. Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Applied Health Economics and Health Policy ◽

10.1007/s40258-012-0007-8 ◽

2013 ◽

Vol 11 (1) ◽

pp. 65-78 ◽

Cited By ~ 28

Author(s):

Elamin H. Elbasha ◽

Jagpreet Chhatwal ◽

Shannon A. Ferrante ◽

Antoine C. El Khoury ◽

Pedro A. Laires

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.09.005 ◽

2020 ◽

Vol 21 ◽

pp. 164-171

Author(s):

Asrul Akmal Shafie ◽

Muhammad Radzi Abu Hassan ◽

Siew Chin Ong ◽

Suchin Virabhak ◽

Yuri Sanchez Gonzalez

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health ◽

10.1016/j.jval.2016.09.963 ◽

2016 ◽

Vol 19 (7) ◽

pp. A513

Author(s):

M Ruggeri ◽

F Romano ◽

A Cicchetti

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Genotype 1 Hepatitis C Virus Treatments For Non-Cirrhotics In The Era Of All-Oral Direct-Acting Antivirals: A Cost-Effectiveness Analysis

Value in Health ◽

10.1016/j.jval.2015.09.1494 ◽

2015 ◽

Vol 18 (7) ◽

pp. A586 ◽

Cited By ~ 1

Author(s):

YJ Zhao ◽

AL Khoo ◽

L Lin ◽

M Teng ◽

CJ Koh ◽

...

Keyword(s):

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Direct Acting Antivirals ◽

Effectiveness Analysis ◽

Direct Acting

Download Full-text